ENVVENO MEDICAL CORPORATION

Historical 13F Holders

Symbol
NVNO
CUSIP
29415J205
All holders as of
Q2 2026
Type
Equity
Class
COM NEW
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 29415J205 since 12/18/2024, newest first.

Filer % of Class Filed
Braeden Lichti 13D/A Amendment 1
0% 9/15/2026
Event 9/11/2026
Perceptive Advisors LLC 13G/A Amendment 8
3.5% 8/14/2026
Event 6/30/2026
Perceptive Advisors LLC 13G/A Amendment 7
10.0% 5/15/2026
Event 3/31/2026
Kingdon Capital Management, L.L.C. 13G/A Amendment 1
5.5% 5/15/2026
Event 3/31/2026
Braeden Lichti 13D
5.1% 2/20/2026
Event 2/20/2026
Northstrive Fund II LP 13D
5.1% 2/20/2026
Event 2/20/2026
Northstrive Fund II LP 13G
5.1% 2/10/2026
Event 2/10/2026
Braeden Lichti 13G
5.1% 2/10/2026
Event 2/10/2026

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q2 17 88.7 k $954 k
2026 Q1 17 101 k $1.02 M